MGManjula Gudhoor

Manjula Gudhoor

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Manjula Gudhoor has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Preliminary development and content validation of mopet–A multidomain oncology pain assessment tool for cancer care setting

    by Manjula Gudhoor, Shrinivas Sonwalkar, Maheen Khazi, Riddhi Patel, M S Ganachari

    Purpose: Cancer pain affects emotional, behavioural, social, and financial well-being beyond physical symptoms. Preliminary development and to perform content validation of a Multidomain Oncology Pain Assessment Tool incorporating physical, emotional, behavioural, sleep-related, social, and financial domains, grounded in the biopsychosocial model of pain. Methods: Mixed-method study design was used to develop and validate a pain assessment questionnaire. In the qualitative phase, focus group discussion, interviews, and expert panel reviews were conducted to generate and refine questionnaire items, ensuring cultural relevance and content validity. In the quantitative phase, healthcare professionals participated in the validation, with reliability assessed via Cronbach's alpha and content validity evaluated using S-CVI/avg scores. Results: In this preliminary content validation, the tool demonstrated excellent internal consistency (Cronbach's α = 0.84–0.94) and strong expert-rated content validity (S-CVI/avg > 0.90). The inclusion of behavioural changes, emotional withdrawal, sleep disturbances, and financial burden ensured a holistic reflection of patients’ lived experiences. Conclusions: This preliminarily validated tool provides a structured, multidimensional, patient-centred framework for assessing cancer-related pain. Further construct validity, criterion validity, and patient-level pilot testing are warranted before broader clinical deployment. Its multidimensional approach supports both pharmacological and non-pharmacological strategies, enabling more accurate and compassionate pain management. Broader multi-centre validation is recommended to strengthen its applicability in diverse clinical settings.

  • Evaluation of pain and quality of life in cancer patients using a multidimensional tool: A study on the impact of pharmacist interventions

    by Riddhi Patel, Shrinivas Sonwalkar, Maheen Khazi, Manjula Gudhoor, M S Ganachari

    Purpose: Cancer pain is one of the most distressing symptoms, severely impairing patients’ quality of life (QoL). This study aimed to assess cancer pain using multidimensional questionnaires and to evaluate the impact of pharmacist-led interventions on pain management and QoL. Methods: A prospective interventional study was conducted among eligible cancer patients. Pain and QoL were assessed using validated multidimensional questionnaires. Pharmacist interventions included counselling, an educational video, and a patient information leaflet. Patients were reassessed post-intervention, and pre- and post-intervention data were analyzed for statistical significance. Results: A total of 147 cancer patients were enrolled, with nearly equal gender distribution. Breast, buccal mucosa, and lung cancers were most prevalent. Surgery was the predominant treatment, followed by radiation and chemotherapy. Pharmacist-led interventions significantly improved QoL across physical, emotional, social, sleep, and behavioral domains (all p < 0.01), with overall QoL scores rising from 4.8 ± 1.25 to 10.5 ± 2.13 (p < 0.001). The economic domain showed comparatively slight improvement, reflecting persistent financial strain. Use of non-pharmacological strategies such as meditation, physiotherapy, and psychosocial support increased significantly post-intervention. Conclusion: A comprehensive assessment with a multidimensional pain questionnaire revealed the broad impact of cancer pain on patients’ lives. Pharmacist-led interventions, combining education, counselling, and supportive care, significantly improved pain control and quality of life across physical, emotional, social, and sleep domains. The persistent economic burden indicates the importance of integrated financial support, but our findings highlight the vital role of clinical pharmacists in delivering holistic, patient-centered cancer pain management.

  • Design, content validation, and reliability assessment of a chemotherapy order template: Expert based content validation

    by Vivek Patil, Madiwalayya S Ganachari, Manjula Gudhoor, Alex Carvalho

    Background: Cancer remains the second leading cause of death worldwide, with nearly 10 million annual deaths. Chemotherapy, though essential, is highly complex and prone to dosing errors, interactions, and adverse effects. To improve safety and standardization, a Chemotherapy Order Template (COT) was developed based on NCCN guidelines. Objective: To design, validate, and assess the reliability of a structured Chemotherapy Order Template that supports safe, accurate, and consistent chemotherapy prescribing in oncology settings. Methods: The validation process included developing the template using NCCN (2025) guidelines, constructing a 22-item Likert-scale tool, obtaining multidisciplinary expert review, and conducting statistical testing using Pearson's correlation and Cronbach's alpha. A total of 54 experts participated. Results: The expert panel comprised 46.30% physicians, 33.33% academicians, and 9.26% clinical pharmacists. The validation tool demonstrated excellent internal consistency with an overall Cronbach's alpha of 0.99. All 22 items showed significant positive correlations (p < 0.01), confirming strong construct validity. Expert feedback led to key enhancements in the COT. Conclusion: The validated COT is a reliable and clinically relevant tool that improves safety, accuracy, and adherence to oncology guidelines in chemotherapy prescribing. Its structured design, based on expert consensus, promotes standardization, reduces medication errors, and supports coordinated, high-quality cancer care.


  • Utilization of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 scale for evaluation of quality of life among cancer patients treated with chemotherapy: A hospital-based observational study

    by Manjula Gudhoor, Aneetta Thankam Mathew, Akul Madiwalayya Ganachari, Gayathri Baiju, Sushrut Sachchidanand Kulkarni, M S Ganachari

    Background: In this new era of cancer management, the quality of life (QOL) is given more importance than the quantity of life. QOL evaluation studies are widely used in oncology to assess the patient's performance in different cancer types and treatment modalities. Objective: To evaluate cancer patients’ QOL after various chemotherapy cycles. Methods: An observational study was performed on cancer patients receiving chemotherapy in the daycare setting of a South Indian Tertiary Care Hospital for 6 months. European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) questionnaire was employed to study the QOL. Results: Precisely, 102 patients participated in the study, out of which the majority were in the 51 to 60 age group (24%). Female participants (65%) were more. Functional scale domains especially physical ability ( P = 0.004), role ( P = 0.033), and emotional functioning ( P = 0.01) were significantly decreased in patients treated with 4 to 6 chemotherapy cycles. Cognitive ability ( P = 0.043) significantly improved in patients treated with more than 6 chemotherapy cycles. Dyspnea ( P = 0.036) was significantly increased in patients treated with 4 to 6 chemotherapy cycles and decreased significantly with the further addition of chemotherapy cycles. Conclusion: Dyspnea is a commonly observed symptom among cancer patients and is often neglected by physicians. Chronic dyspnea can negatively impact a patient's functional ability. Cancer symptoms such as dyspnea should also be given priority and need appropriate treatment. Based on the findings, further interventions can be made to improve the functional ability of cancer patients. Also, studies can be conducted to correlate with cancer rehabilitation programs to improve functional ability and complete the entire chemotherapy cycle.


  • Correlation and Regression Analysis Applied for Types and Number of Blood Transfusions Versus Transfusions Induced ADR Among Pediatric Haemato-Oncology and Thalassemia Patients

    by Manjula Gudhoor, Jessin Jhon, Navaneet Nair, Marion Anna, Abhilasha Sampagar, Madiwalayya Shivakantayya Ganachari

    Introduction: Blood transfusion is a remedial intercession and a fundamental fragment of Current medical services framework. As indicated by the WHO the bonding is an action of moving blood or blood-items taken from a giver into the vasculature and in this manner the flowing blood of the recipient, done by embeddings an IV Needle/Catheter in the patient and followed by use of blood or the blood-items. In any case, the dangers of non-irresistible difficulties have gotten more obvious. These nonirresistible complexities called as adverse transfusion reactions (ATRs) can either be intense in nature or follow a postponed course. Transfusion reaction is any unanticipated impact that happens in a patient during or subsequent to accepting blood and the blood-items. These can be agreed as intense transfusion responses, happening inside 24 hours of transfusion and deferred bonding responses happens inside the space of days or long periods of bonding. Intense and moderate responses can be additionally classified as insusceptible interceded and non-immune-intervened. Methodology: The prospective and observational study was carried at Department of Pediatric Oncology & Thalassemia unit for a period of 6 months. The population required for the study includes patients undergoing blood transfusions. Results: In study data out of 83 units, 61 units of PCV was transfused (73.49%), 6 units of Platelet was transfused (7.22%), 14 units of Whole Blood was transfused (16.86%), 1 units of Fresh Frozen Plasma was transfused (1.20%), and 1 units of RBC was transfused (1.20%). The chance of an ADR occurrence with every transfusion is 0.4. The P value is less than .05 so it is statically significant. It is positively correlated, having a high impact on the number of transfusion and rate of incidence of ADR. Conclusion: While a Blood transfusion is given for unavoidable situation the important factors to be kept under consideration are ADR following transfusion which can be the common complication observed. The study also concludes that the rate of incidence of ADR is increased significantly as the number of transfusion increases.


  • Onco-pharmacist led evaluation of knowledge, attitude & practice (KAP) of safe handling cytotoxic drugs among health care professional's (HCP's) in tertiary care hospital: A hospital based interventional Study

    by Manjula Gudhoor, Madiwalayya Shivakantayya Ganachari, Jyoti K, Geetanjali S Salimath

    Background: Cytotoxic drugs (CDs) are hazardous in nature. But it is necessary for the treatment in cancer patients. The healthcare professionals (HCPs) act as a facilitator through which the manufactured CDs reach the patient. However, safe handling of CDs becomes a primary concern not only for the recipients but also for the HCPs. Methods: On Ethics committee approval, a prospective- interventional study was conducted among HCPs who are involved in handling of CDs in Oncology department of tertiary care hospital. The participants were screened for their eligibility criteria & 73 HCPs were recruited. The initial data was collected from the HCPs through interview & questionnaires. Later the participants were trained by oncology-pharmacist (7–8 months) for safe handling of CDs. After the training the participants were tested again through interview & questionnaires. Results: 73 participants, (75%) nurses & (25%) physicians were included in the study. Among these participants, only 32.87% underwent training on reconstitution whereas 67.12% of the participants didn't undergo any training. The increase in mean score of KAP after the training was observed to be 3.44 ± 4.32, 1.23 ± 1.51 and 1.3 ± 1.01 respectively. Conclusion: The study concludes that mandatory requirement of training for HCPs using SOP's by qualified oncology-pharmacist to minimize the hazardous effects of CDs. It also highlights the improvisation techniques for handling of CDs will enhance the safety profile of HCPs & the patients, which helps in refining the quality of pharmaceutical and health care services provided in the cancer care settings.


  • Quantitative association of educational status and effect of patient counseling among cancer patients: A cross-sectional analysis in a tertiary care hospital in South India

    by Kumar Jyoti, Gudhoor Manjula, Madiwalayya S Ganachari

    Context: Patient Counseling is desirable in chronic disease condition which is influenced by innumerable predictors. Educational status is one of the primary predictor which is usually ignored while considering the effect of patient counseling in cancer patients. Therefore, this study was aimed to determine the measure of association between education level and patient counseling among cancer patients. Design and method: In the cross-sectional analysis, 90 cancer patients in inpatient setting at Oncology department of tertiary care hospital in South India were examined for a 24-week period through pharmacist-patient interview. The data were recorded in well-customized and validated data collection form. Statistical analysis used: Bivariate analysis and linear regression analysis were performed using IBM SPSS Statistics 16.0, USA to assess the empirical relationship between the two determinants: education level and patient counseling. Results: The study participants were aged between 11 to 80 years with 7:11 male to female ratio. Among 90 interviewed patients, 83.3% were counseled. Linear regression analysis demonstrated significant association between education status and patient counseling (p < 0.05). Conclusions: The study findings suggest that poor education status can be a barrier to patient’s ability to seek and act on the counseling provided by the health care professionals. Thus, it recommends improvisation of counseling practice on patients from different educational divisions.


  • Parallel Assessment of Chemotherapy Adherence and Supportive Therapy Adherence on Occurrence and Minimization of Adverse Drug Reactions Among Cancer Patients: A Clinical-Based Observational Study

    by Jyoti Kumar, Manjula Gudhoor, Madiwalayya Shivakantayya Ganachari

    Background: Cancer is a disease that is inevitably treated using chemotherapy, but the cytotoxic drugs used in the treatment have the potency to cause adverse drug reactions (ADRs). Thus, supportive therapy plays an essential role in managing the untoward effects of the cancer drugs in patients. This highlights the importance of medication adherence in managing the disease, mitigating and preventing the occurrence of chemotherapy-induced ADR without compromising the health status of the cancer population. Objective: To assess the adherence to chemotherapy and supportive therapy and to evaluate type and degree of causality of ADRs observed in cancer patients. Methods: On ethics committee approval, a 6-month observational study was conducted among recruited cancer patients undergoing chemotherapy in a tertiary care hospital. Morisky Medication Adherence Measurement Scale–8 was employed to assess the medication adherence, and ADR causality was determined using Naranjo ADR Probability Scale. Results: Ninety cancer patients participated in the study, out of which females were 61.11%. Chemotherapy adherence in comparison to supportive drugs was observed to be more (21.11%). Twelve different combination of ADR were reported in the subjects with variability in the degree of causality assessment. Conclusion and Relevance: The distinction of adherence to the medication used in cancer management with marked level of ADR was well depicted in the study, implicating the necessity of prudent symbiotic practice of an oncology pharmacist, patient, and physician relationship in optimizing the quality of life of cancer patients by imparting vigilant efforts in medication adherence.


  • Application of KW-ANOVA statistics to generate evidence for cytotoxic drug wastage induced financial burden among cancer patients: A clinical pharmacist observation

    by K Jyoti, G Manjula, M S Ganachari

    Background: Very little is known about the effects of drug wastage costs among cancer patients in terms of “financial toxicity” leading to poor health and nonhealth outcomes. But reducing this drug waste is an attractive strategy for cost-cutting with regard to improving the health-related quality of life of the cancer patients. Thus, the objective of the study was to determine drug wastage and to generate evidence for cytotoxic drug waste and financial burden among cancer patients. Methodology: On Ethics Committee approval, a prospective-observational study was conducted in cancer patients. The data were collected in data collection form. Daily monitoring was done to analyze the quantity of drug wastage which was interpreted using KW-ANOVA and further evidence was developed for corrective mitigation strategies applicable to intent drugs. Results: Among 90 patients, 52 patients experienced drug wastage that includes 9 intent drugs which figured out unnecessary monetary units and quantity wastage that range from 80 to 50,000 INR and 10 to 500 mg, respectively. The median price value for cost of drug wastage was 237.30 INR. Conclusion: The study generates evidence that concludes the mandatory requirement of implementation of drug wastage mitigation strategies for the drugs expected to cause wastage. Clinical pharmacist extensively contributes in oncology pharmacy practice setting to identify the intent drugs and to abate the drug wastage among medications intending to cause potential increment in drug expenditure among cancer patients on chemotherapy clinical pharmacist.